412 related articles for article (PubMed ID: 23252898)
1. The role of B cell-activating factor in autoimmune myasthenia gravis.
Lisak RP; Ragheb S
Ann N Y Acad Sci; 2012 Dec; 1274():60-7. PubMed ID: 23252898
[TBL] [Abstract][Full Text] [Related]
2. A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis.
Ragheb S; Lisak R; Lewis R; Van Stavern G; Gonzales F; Simon K
Arch Neurol; 2008 Oct; 65(10):1358-62. PubMed ID: 18852352
[TBL] [Abstract][Full Text] [Related]
3. The expression of BAFF-binding receptors is not altered in multiple sclerosis or myasthenia gravis.
Thangarajh M; Kisiswa L; Pirskanen R; Hillert J
Scand J Immunol; 2007 May; 65(5):461-6. PubMed ID: 17444957
[TBL] [Abstract][Full Text] [Related]
4. Serum BAFF expression in patients with myasthenia gravis.
Kim JY; Yang Y; Moon JS; Lee EY; So SH; Lee HS; Park KD; Choi YC
J Neuroimmunol; 2008 Aug; 199(1-2):151-4. PubMed ID: 18586330
[TBL] [Abstract][Full Text] [Related]
5. The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis.
Thangarajh M; Masterman T; Helgeland L; Rot U; Jonsson MV; Eide GE; Pirskanen R; Hillert J; Jonsson R
J Neuroimmunol; 2006 Sep; 178(1-2):161-6. PubMed ID: 16820216
[TBL] [Abstract][Full Text] [Related]
6. B-cell-activating factor is elevated in serum of patients with myasthenia gravis.
Kang SY; Kang CH; Lee KH
Muscle Nerve; 2016 Dec; 54(6):1030-1033. PubMed ID: 27121160
[TBL] [Abstract][Full Text] [Related]
7. Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis.
Berrih-Aknin S; Ragheb S; Le Panse R; Lisak RP
Autoimmun Rev; 2013 Jul; 12(9):885-93. PubMed ID: 23537509
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of B cell-activating factor in autoimmune pancreatitis.
Yamanishi H; Kumagi T; Yokota T; Azemoto N; Koizumi M; Kobayashi Y; Abe M; Murakami H; Hiasa Y; Matsuura B; Kawamoto H; Yamamoto K; Onji M
Pancreas; 2011 Aug; 40(6):840-5. PubMed ID: 21747319
[TBL] [Abstract][Full Text] [Related]
9. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?
Binard A; Le Pottier L; Saraux A; Devauchelle-Pensec V; Pers JO; Youinou P
J Autoimmun; 2008; 30(1-2):63-7. PubMed ID: 18155417
[TBL] [Abstract][Full Text] [Related]
10. Decrease of CD4(+)CD25(high)Foxp3(+) regulatory T cells and elevation of CD19(+)BAFF-R(+) B cells and soluble ICAM-1 in myasthenia gravis.
Li X; Xiao BG; Xi JY; Lu CZ; Lu JH
Clin Immunol; 2008 Feb; 126(2):180-8. PubMed ID: 18054287
[TBL] [Abstract][Full Text] [Related]
11. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
[TBL] [Abstract][Full Text] [Related]
12. Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors.
Kreuzaler M; Rauch M; Salzer U; Birmelin J; Rizzi M; Grimbacher B; Plebani A; Lougaris V; Quinti I; Thon V; Litzman J; Schlesier M; Warnatz K; Thiel J; Rolink AG; Eibel H
J Immunol; 2012 Jan; 188(1):497-503. PubMed ID: 22124120
[TBL] [Abstract][Full Text] [Related]
13. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.
Zonca M; Mancheño-Corvo P; DelaRosa O; Mañes S; Büscher D; Lombardo E; Planelles L
Tissue Eng Part A; 2012 Apr; 18(7-8):852-9. PubMed ID: 22059379
[TBL] [Abstract][Full Text] [Related]
14. A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells.
McClements M; Williams S; Ball C; Bristow A; Wadhwa M; Meager A
J Immunol Methods; 2008 Aug; 337(1):63-70. PubMed ID: 18625509
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the 5'-flanking region and regulation of transcription of human BAFF-R gene.
Yuan H; Wang Y; Wu X; Wang H; Pu J; Ding W; Wang M; Shen X; Cong H; Zhang L; Zhang M; Ju S
DNA Cell Biol; 2010 Mar; 29(3):133-9. PubMed ID: 20025535
[TBL] [Abstract][Full Text] [Related]
16. An increase in B cell apoptosis by interfering BAFF-BAFF-R interaction with small synthetic molecules.
Moon EY; Yi KY; Lee S
Int Immunopharmacol; 2011 Oct; 11(10):1523-33. PubMed ID: 21620999
[TBL] [Abstract][Full Text] [Related]
17. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
[TBL] [Abstract][Full Text] [Related]
18. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
19. An increase in circulating B cell-activating factor in childhood-onset ocular myasthenia gravis.
Motobayashi M; Inaba Y; Nishimura T; Kobayashi N; Nakazawa Y; Koike K
Pediatr Neurol; 2015 Apr; 52(4):404-9. PubMed ID: 25661289
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of BAFF receptor, a member of the tumor necrosis factor receptor family, in malignant cells of nonhematopoietic origins.
Kohno T; Daa T; Otani H; Shimokawa I; Yokoyama S; Matsuyama T
Genes Cells; 2008 Oct; 13(10):1061-73. PubMed ID: 18775026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
